Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics
- PMID: 25184564
- PMCID: PMC4187679
- DOI: 10.1128/MMBR.00013-14
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics
Abstract
Surface-associated microbial communities, called biofilms, are present in all environments. Although biofilms play an important positive role in a variety of ecosystems, they also have many negative effects, including biofilm-related infections in medical settings. The ability of pathogenic biofilms to survive in the presence of high concentrations of antibiotics is called "recalcitrance" and is a characteristic property of the biofilm lifestyle, leading to treatment failure and infection recurrence. This review presents our current understanding of the molecular mechanisms of biofilm recalcitrance toward antibiotics and describes how recent progress has improved our capacity to design original and efficient strategies to prevent or eradicate biofilm-related infections.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Figures
References
-
- Holsclaw DS. 1980. Cystic fibrosis: overview and pulmonary aspects in young adults. Clin. Chest Med. 1:407–421 - PubMed
-
- Geesey GG, Mutch R, Costertin JW, Green RB. 1978. Sessile bacteria: an important component of the microbial population in small mountain streams. Limnol. Oceanogr. 23:1214–1223. 10.4319/lo.1978.23.6.1214 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
